ArticleThe journal of pediatrics: XPublished
A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years
Regional connection
Listed An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
Publication record
- Type
- Article
- Venue
- The journal of pediatrics: X
- Published
- Topic
- Clinical care
- Subject terms
- Children; Treatment; Cardiovascular disease; Endothelin receptor antagonist; Clinical Trial
- PubMed ID
- 37332660
- PubMed Central ID
- PMC10236545
- Open access
- Yes, open
- Added to directory
- Source checked